Nanopharm leverages its core technologies to enable our clients to gain a comprehensive understanding of their raw materials, manufacture and functionality of drug products. This has enabled acceleration of formulation development programs and has expedited root causes of product failure. The utility of Nanopharm’s core technologies has enabled rapid identification of formulation solutions to dose orally inhaled and nasal drug products in First-in-Human clinical trials.